C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2009
11/05/2009	US20090275021 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
11/05/2009	US20090274792 Novel bacterial phytases and method for producing same
11/05/2009	US20090274770 Cellular extracts
11/05/2009	US20090274729 Media for clostridium bacterium and processes for obtaining a clostridial toxin
11/05/2009	US20090274719 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/05/2009	US20090274715 Tick chitinase
11/05/2009	US20090274714 Tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine
11/05/2009	US20090274708 Recombinant Toxin Fragments
11/05/2009	US20090274707 Anti-IL-12 Antibodies, Nucleic Acids Encoding Antibodies, and Methods of Production
11/05/2009	US20090274705 Il-13 binding agents
11/05/2009	US20090274701 Chlamydia pneumoniae polynucleotides and uses thereof
11/05/2009	US20090274699 Ul16 binding protein 4
11/05/2009	US20090274688 Antibodies to OPGL
11/05/2009	US20090274680 Human Phospholipases
11/05/2009	US20090274666 B7-h1, a novel immunoregulatory molecule
11/05/2009	US20090274653 Interleukin-2 mutants with reduced toxicity
11/05/2009	CA2723197A1 Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
11/05/2009	CA2722994A1 Isolated peptides having phospholipase inhibitory activity
11/04/2009	EP2113514A1 Method for creating hypoallergenic glycoproteins in mutated or genetically modified plants or plant cells and mutated or genetically modified plants and plant cells for creating hypoallergenic glycoproteins
11/04/2009	EP1692180B1 Anti-il-20 antibodies and binding partners and methods of using in inflammation
11/04/2009	EP1668114B1 Polypeptide display libraries and methods of making and using thereof
11/04/2009	EP1375664B1 Method for the secretion and production of protein
11/04/2009	EP1125134B1 S100 proteins and autoantibodies as serum markers for cancer
11/04/2009	EP1032660B1 Method of identifying binding site domains that retain the capacity of binding to an epitop
11/04/2009	EP1004299B1 Vaccine precursors, vaccines for treating tumors
11/03/2009	US7612442 Semiconductor device
11/03/2009	US7612192 Neisseria genomic sequences and methods of their use
11/03/2009	US7612183 Antibodies to myelin associated glycoprotein (MAG); neurological diseases/disorders
11/03/2009	US7612182 Anti-IL-6 antibodies, compositions, methods and uses
11/03/2009	US7612181 Dual variable domain immunoglobulin and uses thereof
11/03/2009	US7612180 Humanized L243 antibodies
11/03/2009	US7612179 Alzheimer's disease, systemic amyloidosis and other amyloid disorders; kits
11/03/2009	US7612178 Anti-IGF-1R antibodies and uses thereof
11/03/2009	US7612175 Having an SR structure and a collectin-like structure ; drug screening; , diabetic complications and Alzheimer's disease, hyper beta -lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypo alpha -lipoproteinemia, transplantation, atherectomy, post angiogenic restenosis, bacterial infections
11/03/2009	US7612174 Scavenger receptor
11/03/2009	US7612083 Urea substituted imidazoquinoline ethers
11/03/2009	US7612044 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/03/2009	US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
11/03/2009	US7611904 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
11/03/2009	US7611893 Metal-binding therapeutic peptides
11/03/2009	US7611881 Due to one or more amino acid modifications in a xylanase polypeptide or fragment produces a variant xylanase polypeptide which has an altered sensitivity to a xylanase inhibitor as compared with the parent enzyme
11/03/2009	US7611866 Selection of bacterial inner-membrane anchor polypeptides
11/03/2009	US7611865 Genetic engineering
11/03/2009	US7611855 Permits accurate assay of a target substance in a specimen by the use of two types of characteristic antibodies
11/03/2009	US7611724 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease
11/03/2009	US7611708 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
11/03/2009	US7611706 RG1 antibodies and uses thereof
11/03/2009	US7611699 Reducing the growth of cancer cells in a mammal by administering polypeptide of the invention;
11/03/2009	CA2418961C Anti-il-12 antibodies, compositions, methods and uses
11/03/2009	CA2191064C Pantropic neurotrophic factors
11/03/2009	CA2181548C Zinc finger protein derivatives and methods therefor
11/03/2009	CA2118243C Methods and compositions for monitoring cellular processing of .beta.-amyloid precursor protein
11/03/2009	CA2105618C Humanized antibodies to ganglioside gm2
10/2009
10/29/2009	WO2009131919A2 Polymerases for incorporating modified nucleotides
10/29/2009	WO2009131661A2 Methods and compositions for the specific inhibition of hepatitis c virus (hcv) by double-stranded rna
10/29/2009	WO2009131643A1 Immunoassay for specific determination of s-adenosymethionine and analogs thereof in biological samples
10/29/2009	WO2009131568A1 Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
10/29/2009	WO2009131239A1 Stable polyvalent antibody
10/29/2009	WO2009131052A1 Method for production of defatted soymilk peptide
10/29/2009	WO2009091994A3 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
10/29/2009	US20090270595 Il-1 related polypeptides
10/29/2009	US20090270592 Purified TNFR preparations
10/29/2009	US20090270591 Novel surface antigen
10/29/2009	US20090270489 Long-acting polypeptides and methods of producing same
10/29/2009	US20090270333 Methods of using motilin homologs
10/29/2009	US20090270324 Complement depletion using recombinant human c-3 derivatives
10/29/2009	US20090270268 Methods for Obtaining Immortalized Antibody Secreting Cells
10/29/2009	US20090270265 Molecular Characteristics of Non-Small Cell Lung Cancer
10/29/2009	US20090269844 Nucleic acids encoding a receptor for il-17 homologous polypeptides
10/29/2009	US20090269840 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
10/29/2009	US20090269828 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts
10/29/2009	US20090269811 Il-1 related polypeptides
10/29/2009	US20090269810 Method for enhancing recombinant antibody production
10/29/2009	US20090269809 Thermostable ribonuclease h
10/29/2009	US20090269808 Virus coat protein variants with self-subtracting properties
10/29/2009	US20090269807 Compositions and Methods for the Expression of Selenoproteins in Eukaryotic Cells
10/29/2009	US20090269806 Process for producing dipeptides
10/29/2009	US20090269805 Novel Lipolytic Enzyme ELIP
10/29/2009	US20090269804 Methods for refolding proteins containing free cysteine residues
10/29/2009	US20090269803 In Vivo Generation of Dna, Rna, Peptide, and Protein Libraries
10/29/2009	US20090269802 Alpha 1,4-galactosyltransferase and dna encoding thereof
10/29/2009	US20090269801 Vector to Induce Expression of Recombinant Proteins under Anoxic or Microaerobic Conditions
10/29/2009	US20090269783 B7-H2 molecules, novel members of the B7 family and uses thereof
10/29/2009	US20090269751 Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
10/29/2009	US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids
10/29/2009	US20090269371 Process for the production of monoclonal antibodies
10/29/2009	US20090269350 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
10/29/2009	US20090269349 Antigenic polypeptides
10/29/2009	US20090269338 Humanized anti-factor d antibodies and uses thereof
10/29/2009	US20090269332 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
10/29/2009	US20090269327 isolated from Coprinus clastophyllus; for treating celiac disease caused by proline abundant gluten
10/29/2009	US20090269323 Non-amphiphile-based water-in-water emulsion and uses thereof
10/29/2009	US20090269277 Multivalent Immunoglobulin-Based Bioactive Assemblies
10/28/2009	EP2112222A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/28/2009	EP2112166A2 Human monoclonal antibodies to CTLA-4
10/28/2009	EP2112165A2 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
10/28/2009	EP2112161A2 Peptides that lower blood glucose levels
10/28/2009	EP2112157A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/28/2009	EP1735451B1 Mutated prokaryotic cells with high secretion-levels
10/28/2009	EP1730277B1 Ligational encoding using building block oligonucleotides

1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 1125